Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
marked decrease » marked increase (Expand Search)
reported case » reported cases (Expand Search), reported use (Expand Search), reported race (Expand Search)
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
marked decrease » marked increase (Expand Search)
reported case » reported cases (Expand Search), reported use (Expand Search), reported race (Expand Search)
-
1
-
2
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
3
-
4
-
5
-
6
-
7
Data Sheet 1_Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.docx
Published 2024“…However, certain genetic profiles, such as BRCA1/2 mutations, high tumor mutational burden (TMB), or microsatellite instability-high (MSI-H), may enhance sensitivity to these therapies. This report presents two cases of advanced pancreatic cancer with BRCA1/2 mutations treated with a combination of chemotherapy and immune checkpoint inhibitors. …”
-
8
Multivariate logistic regression of significant variables stratified by age.
Published 2025Subjects: -
9
-
10
Data Sheet 1_Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.pdf
Published 2025“…Currently, no standardized therapeutic protocol exists for DSP-MG due to its scarcity and clinical heterogeneity. Herein, we report a case of a 68-year-old female patient with DSP-MG who showed significant clinical improvement during an acute exacerbation after treatment with the FcRn antagonist efgartigimod, following the failure of conventional therapy. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20